Acupoint Transcutaneous Electrical Nerve Stimulation in Hospitalized COPD Patients With Severe Dyspnoea
Efficacy of Transcutaneous Electrical Stimulation at Dingchuan (EX-B1) in Hospitalized COPD Patients With Severe Dyspnoea: Patient and Assessor Blinded Randomized Placebo Control Trial
1 other identifier
interventional
60
1 country
3
Brief Summary
Introduction: Chronic obstructive pulmonary disease (COPD) presents with a gradual reduction and little bitterness reversible airflow causing shortness of breath, chronic cough and sputum abnormal. Patients with COPD often suffer exacerbations of their symptoms, particularly dyspnea, causing hospital admissions. Recent studies have shown that acupuncture stimulation transcutánea (AcuTENS) Dingchuan point (EX-B1) could help reduce dyspnea in patients with COPD. Objective: The aim of this study was to evaluate the possible utility of adding to the usual treatment stimulation AcuTENS in COPD patients admitted with severe dyspnea. Methodology: Patients who agree to participate will be randomly divided into two groups. The intervention group will receive a daily treatment, during the period of hospitalization, 45 minutes stimulation at acupuncture point AcuTENS Dingchuan (EX-B1), while the control group performed the same procedure with a device TENS simulated. The extent of dyspnea in both groups as well as the number of days of hospitalization and the number of drugs consumed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2016
CompletedFirst Posted
Study publicly available on registry
December 21, 2016
CompletedStudy Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedOctober 2, 2018
September 1, 2018
1.2 years
November 30, 2016
September 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dyspnoea
Change from baseline using the modified Borg scale
At baseline, day 1, day 2, day 3 day 4 and day 5 of the study.
Secondary Outcomes (10)
Hospitalization days
Up to 1 months after discharge
Quantity of drug administered
Up to 1 months after discharge
Peak expiratory flow
At baseline, day 1, day 2, day 3 day 4 and day 5 of the study.
PaO2
At baseline, day 1, day 2, day 3 day 4 and day 5 of the study. (only if there is a medical indication for it)
Mortality
Up to 3 months after discharge
- +5 more secondary outcomes
Study Arms (2)
AcuTENS
EXPERIMENTALStimulation using a portable TENS electrostimulation device at Dingchuan point using a biphasic rectangular wave with a frequency of 2Hz and a pulse width of 200 ms. The stimulation will be achieved using the highest intensity tolerated by the patient without pain during 40 minuts. Once a day during 5 consecutive days.
Sham AcuTENS
SHAM COMPARATORStimulation using a modified portable TENS electrostimulation device at Dingchuan point with no electrical output, even though the screen will light up and display the same data as in the unmodified device during 40 minuts. Patients in this group will be informed that, due to the frequency of stimulation, it is unlikely that they will feel the electric stimulation. Once a day during 5 consecutive days.
Interventions
Stimulation of acupuncture point Dingchuan using transcutaneous electrical nerve stimulation (TENS) instead of needles
Eligibility Criteria
You may qualify if:
- Patients aged between 45 and 70 years, with a diagnose of COPD according to the GOLD guidelines.
- Patients with one episode of hospitalization for COPD exacerbation in the past year, but not more than three episodes.
- Smoking habit history of more than 10 packages-year.
- Patients able to correctly understand and answer the modified Borg scale.
- Patiens with an initial degree of dyspnoea with a score of at least 5 in the modified Borg scale.
- Patients recruited for the study during the first 48 hours of their hospitalization.
- Patients who accept to participate in the study and sign the informed consent.
You may not qualify if:
- Patients with any contraindication for transcutaneous electrical stimulation (patiens with pacemakers, skin injury in the application area ...).
- Patiens with any cardiovascular, neurological or psychiatric disease that may affect the perception of dyspnea.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hospital Sant Joan de Déu de Manresa
Manresa, Barcelona, Spain
Parc Sanitari de Sant Joan de Déu
Sant Boi de Llobregat, Barcelona, 08830, Spain
Hospital del Mar
Barcelona, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2016
First Posted
December 21, 2016
Study Start
April 1, 2018
Primary Completion
June 1, 2019
Study Completion
September 1, 2019
Last Updated
October 2, 2018
Record last verified: 2018-09